5-Hydroxytryptamine and functional bowel disorders

Area of Science:

• Gastroenterology
• Neuroscience
• Pharmacology

Background:

• 5-hydroxytryptamine (5-HT) is implicated in the etiology of irritable bowel syndrome (IBS).
• Key 5-HT receptors in the gut include 5-HT3 and 5-HT4 types, influencing neuronal sensitivity and gastrointestinal function.

Purpose of the Study:

• To review the role of 5-HT as a sensitizing agent in IBS.
• To evaluate the potential therapeutic benefits of targeting 5-HT receptors for IBS symptom management.

Main Methods:

• Review of existing literature on 5-HT, its receptors, and their role in IBS.
• Analysis of the mechanisms by which 5-HT3 and 5-HT4 receptor antagonists may affect IBS symptoms and bowel function.

Main Results:

• 5-HT enhances visceral and enteric neuronal sensitivity via 5-HT3 and 5-HT4 receptors, respectively.
• 5-HT3 antagonists may reduce IBS pain but risk constipation and affect normal bowel function.
• 5-HT4 antagonists reduce 5-HT-induced hypersensitivity without impairing normal bowel function, offering potential for IBS symptom relief.

Conclusions:

• Targeting 5-HT4 receptors presents a promising therapeutic strategy for IBS.
• 5-HT4 receptor antagonists may alleviate IBS symptoms like diarrhea and pain while avoiding constipation associated with 5-HT3 antagonists.